Market Overview:
IUCD is a contraceptive device that is inserted into the uterus. It may be hormonal or non-hormonal. The type of IUCD also depends on the shape- T shaped, V shaped or others. The market for global intrauterine contraceptive devices (IUCD) is expected to grow at a CAGR of 5.8% from 2018 to 2030. Some of the factors that are driving the growth of this market are rising awareness about contraception, increasing incidence of unintended pregnancies and growing demand for long-term reversible contraceptives.
 Industry Outlook.svg)
Product Definition:
Intrauterine contraceptive devices (IUCDs) are T-shaped plastic or metal devices that are inserted into the uterus to prevent pregnancy. IUCDs work by preventing the sperm from reaching and fertilizing an egg. There are two types of IUCDs: copper-containing and hormone-releasing. Copper-containing IUCDs release a small amount of copper that interferes with sperm movement and function. Hormone-releasing IUCDs release hormones, such as progestin, into the uterus which can thin the lining of the uterus and decrease sperm movement.
Non-hormonal:
Non-hormonal Intrauterine Devices (NHC-IUD) are a new class of contraceptive devices that are currently being used in the market. They consist of two parts, an intrauterine device and a remote control system which is held in place by law enforcement agents such as copper or zinc oxide.
Hormonal:
Hormonal is a drug or medication used by the female body to prevent pregnancy. Hormonal IUDs are one of the most effective birth control methods as they work by preventing fertilization. The hormonal IUD market is expected to witness lucrative growth over the forecast period owing to increasing awareness about sexual health and family planning, rising number of unintended pregnancies, and government initiatives for improving women’s healthcare across all regions.
Application Insights:
The others application segment includes J shapes, D shapes and T-shaped IUCDs. Other than the traditional T-shaped IUD, there are other variants such as the progestin-releasing intrauterine system (PIRUS) that is used for emergency contraception. The hormonal IUDs include Mirena and Kyleena that are used for birth control purposes.
The popularity of these devices has increased due to their ability to prevent unintended pregnancies with less side effects compared to oral contraceptives or condoms among women who have had a baby recently or after childbirth. Moreover, they also act as an effective method of birth control during breastfeeding owing to its high effectiveness in preventing ovulation and fertilization in lactating mothers. This factor is expected to drive market growth over the forecast period among lactating women globally.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about contraceptives, rising disposable income of women, and availability of various IUCDs at an affordable price. Moreover, growing population in this region coupled with a high number of unmet needs regarding family planning is anticipated to fuel growth over the coming years.
Europe held a significant share in 2017 owing to high demand for modern contraceptive devices from countries such as Germany and U.K., which are among the top 10 countries having highest birth rate globally (based on UN data). In addition, presence of major players such as Bayer AG; Merck Group; Intra-uterine Devices A/S; Medtronic plc.; Novo Nordisk A/S; Unilife Corporation that are engaged in intrauterine device development will drive regional growth over the forecast period.
Growth Factors:
- Increasing awareness about contraception and intrauterine contraceptive devices (IUCD) in developing countries.
- Government initiatives to promote the use of IUCDs, especially in developing countries.
- Rising prevalence of sexually transmitted infections (STIs), which is driving the demand for IUCDs as a means of contraception and disease prevention.
- Growing popularity of long-acting reversible contraceptives (LARCs) among women, which is benefiting the growth of the IUCD market worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intrauterine Contraceptive Devices (IUCD) Market Research Report
By Type
Non-hormonal, Hormonal, Inert
By Application
T Shapes, V Shapes, Others
By Companies
Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International, Melbea AG, Pregna International Limited, Bayer Healthcare AG, SMB Corporation, Mona Lisa N.V
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Intrauterine Contraceptive Devices (IUCD) Market Report Segments:
The global Intrauterine Contraceptive Devices (IUCD) market is segmented on the basis of:
Types
Non-hormonal, Hormonal, Inert
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
T Shapes, V Shapes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer Healthcare AG
- Teva Pharmaceutical Industries Ltd
- Actavis PLC
- Medicines360
- Trimedic Supply Network Ltd
- Medisafe Distribution Inc
- Pace Pharmaceuticals Inc
- DKT International
- Melbea AG
- Pregna International Limited
- Bayer Healthcare AG
- SMB Corporation
- Mona Lisa N.V
 Market Overview.svg)
Highlights of The Intrauterine Contraceptive Devices (IUCD) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-hormonal
- Hormonal
- Inert
- By Application:
- T Shapes
- V Shapes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrauterine Contraceptive Devices (IUCD) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intrauterine contraceptive devices (IUCDs) are a type of birth control that is inserted into the uterus. They work by preventing sperm from reaching the egg. IUCDs can be used in combination with other forms of contraception, such as condoms or birth control pills.
Some of the key players operating in the intrauterine contraceptive devices (iucd) market are Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International, Melbea AG, Pregna International Limited, Bayer Healthcare AG, SMB Corporation, Mona Lisa N.V.
The intrauterine contraceptive devices (iucd) market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intrauterine Contraceptive Devices (IUCD) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intrauterine Contraceptive Devices (IUCD) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intrauterine Contraceptive Devices (IUCD) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intrauterine Contraceptive Devices (IUCD) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intrauterine Contraceptive Devices (IUCD) Market Size & Forecast, 2020-2028
4.5.1 Intrauterine Contraceptive Devices (IUCD) Market Size and Y-o-Y Growth
4.5.2 Intrauterine Contraceptive Devices (IUCD) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Non-hormonal
5.2.2 Hormonal
5.2.3 Inert
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 T Shapes
6.2.2 V Shapes
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intrauterine Contraceptive Devices (IUCD) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intrauterine Contraceptive Devices (IUCD) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Non-hormonal
9.6.2 Hormonal
9.6.3 Inert
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 T Shapes
9.10.2 V Shapes
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Non-hormonal
10.6.2 Hormonal
10.6.3 Inert
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 T Shapes
10.10.2 V Shapes
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Non-hormonal
11.6.2 Hormonal
11.6.3 Inert
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 T Shapes
11.10.2 V Shapes
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Non-hormonal
12.6.2 Hormonal
12.6.3 Inert
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 T Shapes
12.10.2 V Shapes
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Non-hormonal
13.6.2 Hormonal
13.6.3 Inert
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 T Shapes
13.10.2 V Shapes
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intrauterine Contraceptive Devices (IUCD) Market: Competitive Dashboard
14.2 Global Intrauterine Contraceptive Devices (IUCD) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer Healthcare AG
14.3.2 Teva Pharmaceutical Industries Ltd
14.3.3 Actavis PLC
14.3.4 Medicines360
14.3.5 Trimedic Supply Network Ltd
14.3.6 Medisafe Distribution Inc
14.3.7 Pace Pharmaceuticals Inc
14.3.8 DKT International
14.3.9 Melbea AG
14.3.10 Pregna International Limited
14.3.11 Bayer Healthcare AG
14.3.12 SMB Corporation
14.3.13 Mona Lisa N.V
